ChemoCentryx reveals terms of NASDAQ IPO

ChemoCentryx has revealed its IPO terms: 4 mn shares at $14 to$16. The company is hoping to raise $60 mn and is looking to trade on NASDAQ under the symbol CCXI. Its lead underwriters are JP Morgan and C)" href="http://www.insideipo.com/tag/citigroup">Citigroup. According to Renaissance Capital, ChemoCentryx is the fourth biopharm to set its IPO terms this month.

Click here for FREE email alerts from Inside IPO >>

Source: Renaissance Capital